propafenone has been researched along with lidocaine in 74 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 36 (48.65) | 18.7374 |
1990's | 18 (24.32) | 18.2507 |
2000's | 12 (16.22) | 29.6817 |
2010's | 7 (9.46) | 24.3611 |
2020's | 1 (1.35) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Bennis, K; Ducki, S; Lesage, F; Vivier, D | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Kato, R; Koide, M; Miyahara, T; Sotobata, I; Toyama, J; Ukai, M; Yasui, S; Yokota, M | 1 |
Rabkin, SW | 1 |
Benz, I; Kohlhardt, M | 2 |
Magnani, A; Occhetta, E; Perucca, A; Piccinino, C; Rognoni, G; Rossi, P | 1 |
Desai, DM; Gal, J; Meyer-Lehnert, S | 1 |
Grant, AO; Starmer, CF | 1 |
Hashimoto, K; Ishii, M; Komori, S; Mitsuhashi, H | 1 |
Bell, P; Martorana, M; Winslow, E | 1 |
Lampert, S; Lown, B; Podrid, PJ; Ravid, S | 1 |
Hoffman, BF; Spinelli, W | 1 |
Fichtner, H; Fröbe, U; Herzig, JW; Kohlhardt, M | 1 |
Aguglia, F; De Marzio, P; Gnecchi, M | 1 |
Somberg, J | 1 |
Roden, DM; Siddoway, LA; Woosley, RL | 1 |
Huang, SK; Marcus, FI | 1 |
Agarwal, JB; Ambrosioni, E; Bracchetti, D; Helfant, RH; Naccarella, F; Weintraub, WS | 1 |
Puddu, PE; Rouet, R | 1 |
Atallah, G; Ferry, S; Kirkorian, G; Marchand, A; Mathieu, MP; Moleur, P; Stahl, C; Touboul, P; Vrancea, F; Zoheir, F | 1 |
Allessie, MA; Bonke, FI; Lammers, WJ; Rensma, PL; Schalij, MJ | 1 |
Feld, GK; Kirsten, E; Nademanee, K; Singh, BN | 1 |
Schwartz, PJ; Vanoli, E | 1 |
Hirosawa, K; Kasanuki, H; Onishi, S | 1 |
Podrid, PJ | 1 |
Sanna, GP | 1 |
Schmitz, W | 1 |
Attuel, P; Coumel, P; Georgiopoulos, G; Halkidis, H; Leclercq, JF; Maisonblanche, P | 1 |
Somberg, JC | 1 |
Himmler, C; Klein, G; Neiss, A; Schlegl, J; Wirtzfeld, A | 1 |
Lüderitz, B | 1 |
Ericsson, CG; Eriksson, S; Olsson, G; Rehnqvist, N; Svensson, G | 1 |
Gebhardt, A; Hilpert, P; Schmuderer, R | 1 |
Bettini, R; Dal Forno, P; Disertori, M; Furlanello, F; Gramegna, L; Inama, G; Vergara, G | 1 |
Heger, JJ; Prystowsky, EN; Zipes, DP | 1 |
Agarwal, JB; Bracchetti, D; Helfant, RH; Naccarella, FF; Weintraub, WS | 1 |
Karagueuzian, HS; Katoh, T; Mandel, WJ; McCullen, A; Peter, T | 1 |
Bernardes, Rde C; Borges, MZ; de Almeida, RC; de Souza, LS; Marino, MA; Marino, RL; Rabelo, RC; Rabelo, W; Serufo, JC | 1 |
Mouselimis, N; Wester, HA | 1 |
Atallah, G; Kirkorian, G; Moleur, P; Touboul, P | 1 |
Fujimoto, T; Karagueuzian, HS; Katoh, T; Mandel, WJ; McCullen, A; Peter, T | 1 |
Glogar, D; Laimer, H; Zilcher, H | 1 |
Ledda, F; Mantelli, L; Manzini, S; Mugelli, A | 1 |
Carlsson, B; Drvota, V; Häggblad, J; Sylvén, C | 1 |
Beleslin, BB; Dekleva, MN | 1 |
Campbell, TJ; Wyse, KR; Ye, VZ | 1 |
Liu, L; Tang, YN; Wang, ZY; Zhang, WL | 1 |
Gutiérrez-Larraya, F; Jabón, A | 1 |
Bellone, P; Spirito, P; Vecchio, C | 1 |
Higuchi, M; Itomine, T; Matsuzaki, T; Nakasone, J; Noguchi, K; Ojiri, Y; Sakanashi, M; Shiroma, N | 1 |
Cronenberger, CL; Griffith, RK; Lalka, D | 1 |
Chow, MS; Fan, C; Kluger, J; O'Rangers, EA; Pharand, C; Ujhelyi, MR | 1 |
Akaike, N; Inomata, N; Ishihara, T; Ohno, T | 1 |
Decrinis, M; Kasper, K; Pilger, E; Schwarzl, I; Stark, G; Stark, U; Tritthart, HA | 1 |
Iwasa, A; Matsunaga, T; Okumura, K; Tabuchi, T; Tayama, S; Tsuchiya, T; Tsunoda, R; Yasue, H | 1 |
Hancox, JC; Paul, AA; Witchel, HJ | 1 |
Furuichi, K; Inamura, K; Kitada, C; Matsushime, H; Miyake, A; Mochizuki, S; Nozawa, K; Okada, H; Sano, Y; Yokoi, H | 1 |
Fujimura, A; Sakamoto, K; Shiga, T; Tsuruoka, S; Wakaumi, M | 1 |
Antzelevitch, C; Belardinelli, L; Burashnikov, A; Di Diego, JM; Zygmunt, AC | 1 |
Faggioni, M; Hasdemir, C; Hwang, HS; Knollmann, BC; Laver, D; Mehra, D; Turhan, K; Yin, H | 1 |
Cupić, V; Gojković-Bukarica, L; Heinle, H; Ivković, B; Novaković, R; Vladimirov, S | 1 |
Deguchi, N; Hamaguchi, S; Hashimoto, T; Hiiro, H; Kaneko, M; Mizoguchi, M; Namekata, I; Takahashi, Y; Tanaka, H | 1 |
10 review(s) available for propafenone and lidocaine
Article | Year |
---|---|
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Structure; Neuroprotective Agents; Pain; Potassium Channels, Tandem Pore Domain; Structure-Activity Relationship | 2016 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Clinical pharmacology of old and new antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Biological Availability; Bretylium Compounds; Disopyramide; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Tocainide | 1985 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil | 1986 |
Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Propafenone; Propiophenones; Tocainide | 1985 |
[Electrophysiological classification of newer antiarrhythmic drugs (author's transl)].
Topics: Action Potentials; Adrenergic beta-Antagonists; Anilides; Animals; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Calcium; Disopyramide; Electrophysiology; Humans; Lidocaine; Mexiletine; Piperidines; Propafenone; Propiophenones; Quinidine; Sodium; Tocainide | 1980 |
[New antiarrythmic drugs: mexiletine, tocainide, lorcainide, encainide, flecainide, propafenone, cipralan, sotalol].
Topics: Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Electrophysiology; Encainide; Flecainide; Hemodynamics; Humans; Imidazoles; Lidocaine; Mexiletine; Piperidines; Propafenone; Propiophenones; Sotalol; Tocainide | 1982 |
[Tachycardias: considerations in childhood in the 90s].
Topics: Adenosine; Adolescent; Adult; Amiodarone; Atrial Flutter; Child; Child, Preschool; Electrocardiography; Ergometry; Flecainide; Heart; Heart Ventricles; Humans; Infant; Infant, Newborn; Lidocaine; Middle Aged; Propafenone; Sotalol; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Tachycardia, Ventricular | 1993 |
The hepatic first-pass metabolism of problematic drugs.
Topics: Animals; Anti-Arrhythmia Agents; Humans; Lidocaine; Liver; Metabolic Clearance Rate; Models, Biological; Nitroglycerin; Pharmaceutical Preparations; Propafenone; Propranolol; Verapamil | 1993 |
6 trial(s) available for propafenone and lidocaine
Article | Year |
---|---|
A comparative evaluation of the effects of propafenone and lidocaine on early ventricular arrhythmias after acute myocardial infarction.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Female; Heart Rupture, Post-Infarction; Humans; Lidocaine; Male; Middle Aged; Myocardial Infarction; Propafenone; Random Allocation; Time Factors | 1988 |
[Efficacy of anti-arrhythmia agents].
Topics: Adult; Aged; Ajmaline; Androstanols; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Lidocaine; Male; Middle Aged; Placebos; Propafenone; Propiophenones | 1980 |
Comparative investigation of the antiarrhythmic effect of propafenone (Rytmonorm) and lidocaine in patients with ventricular arrhythmias during acute myocardial infarction.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Heart Rate; Heart Ventricles; Humans; Lidocaine; Myocardial Infarction; Propafenone; Propiophenones | 1984 |
[Comparative studies of tocainide and propafenone in the treatment of ventricular arrhythmias].
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrocardiography; Female; Heart Ventricles; Humans; Lidocaine; Male; Middle Aged; Propafenone; Propiophenones; Tocainide | 1984 |
[Ventricular tachycardia--Effects of propafenon by intravenous route. Comparative study with lidocaine].
Topics: Adult; Aged; Clinical Trials as Topic; Electrocardiography; Female; Humans; Injections, Intravenous; Lidocaine; Male; Middle Aged; Propafenone; Propiophenones; Tachycardia | 1981 |
[The effect of anti-arrhythmic drugs on myocardial function (author's transl)].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Coronary Disease; Depression, Chemical; Disopyramide; Echocardiography; Humans; Lidocaine; Mexiletine; Middle Aged; Myocardial Contraction; Placebos; Propafenone; Propiophenones; Tocainide | 1982 |
58 other study(ies) available for propafenone and lidocaine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Pharmacokinetics and pharmacodynamics of class I antiarrhythmic agents after a single oral administration].
Topics: Administration, Oral; Anti-Arrhythmia Agents; Aprindine; Flecainide; Humans; Imidazoles; Lidocaine; Mexiletine; Piperidines; Propafenone | 1992 |
Effect of antiarrhythmic drugs on choline uptake in cardiac cells in culture.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cells, Cultured; Chick Embryo; Choline; Dose-Response Relationship, Drug; Encainide; Flecainide; Heart; Lidocaine; Myocardium; Propafenone; Tocainide | 1992 |
Responsiveness of cardiac Na+ channels to antiarrhythmic drugs: the role of inactivation.
Topics: Animals; Anti-Arrhythmia Agents; Cells, Cultured; Dose-Response Relationship, Drug; Fluorides; Heart; Heart Rate; Lidocaine; Myocardium; Propafenone; Quinidine; Sodium Channels | 1991 |
[Termination of ventricular tachycardia by noninvasive methods].
Topics: Cardiac Pacing, Artificial; Heart Ventricles; Humans; Lidocaine; Male; Middle Aged; Propafenone; Tachycardia | 1991 |
Reversed-phase LC resolutions of chiral antiarrhythmic agents via derivatization with homochiral isothiocyanates.
Topics: Anti-Arrhythmia Agents; Chromatography, Liquid; Flecainide; Humans; Indicators and Reagents; Lidocaine; Male; Mexiletine; Propafenone; Thiocyanates; Tocainide | 1990 |
Phasic ion channel blockade. A kinetic model and parameter estimation procedure.
Topics: Animals; Binding Sites; Biological Transport; Electric Stimulation; In Vitro Techniques; Ion Channels; Kinetics; Lidocaine; Membrane Potentials; Muscles; Propafenone; Propiophenones; Quinidine; Solubility; Stochastic Processes | 1985 |
Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels; Dogs; Epinephrine; Female; Ion Channels; Lidocaine; Ligation; Male; Ouabain; Propafenone; Propiophenones; Sodium; Tocainide | 1985 |
Electrophysiologic effects of Org 7797, a new steroidal antiarrhythmic agent: comparison with class 1a, 1b, and 1c drugs.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Disopyramide; Electric Stimulation; Estrenes; Female; In Vitro Techniques; Lidocaine; Male; Membrane Potentials; Propafenone; Purkinje Fibers; Sodium Channels; Swine | 1989 |
Congestive heart failure induced by six of the newer antiarrhythmic drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Encainide; Female; Heart Failure; Humans; Lidocaine; Male; Mexiletine; Middle Aged; Moricizine; Phenothiazines; Piperidines; Propafenone; Risk Factors; Stroke Volume; Tocainide | 1989 |
Mechanisms of termination of reentrant atrial arrhythmias by class I and class III antiarrhythmic agents.
Topics: Animals; Anti-Arrhythmia Agents; Disopyramide; Dogs; Electrocardiography; Flecainide; Heart Conduction System; Heart Rate; Lidocaine; Piperidines; Propafenone; Sotalol | 1989 |
On the mechanism of drug-induced blockade of Na+ currents: interaction of antiarrhythmic compounds with DPI-modified single cardiac Na+ channels.
Topics: Animals; Anti-Arrhythmia Agents; Catecholamines; Cells, Cultured; Imidazolines; Lidocaine; Myocardium; Prajmaline; Propafenone; Rats; Sodium; Sodium Channels | 1989 |
Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, Premature; Drug Therapy, Combination; Electrocardiography; Heart Atria; Heart Ventricles; Hemodynamics; Humans; Lidocaine; Male; Mexiletine; Middle Aged; Myocardial Infarction; Propafenone; Propiophenones; Propylamines; Tachycardia | 1985 |
[Myocardial distribution of C-14 lidocaine and C-14 propafenone in relation to regional myocardial blood flow in a model of chronic-phase myocardial infarct].
Topics: Animals; Carbon Radioisotopes; Coronary Circulation; Dogs; Lidocaine; Microspheres; Myocardial Infarction; Myocardium; Propafenone | 1988 |
Are different pharmacokinetic properties of lidocaine versus propafenone in normal as compared to ischemic myocardium responsible for different electrophysiologic effects which help preventing arrhythmias?
Topics: Animals; Arrhythmias, Cardiac; Coronary Circulation; Electrophysiology; Guinea Pigs; In Vitro Techniques; Lidocaine; Myocardial Infarction; Myocardium; Propafenone | 1988 |
Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs.
Topics: Acetylcholine; Animals; Arrhythmias, Cardiac; Autonomic Nervous System; Dogs; Female; Heart Conduction System; Lidocaine; Male; Neural Conduction; Ouabain; Physical Exertion; Propafenone; Quinidine; Refractory Period, Electrophysiological; Sotalol | 1988 |
Hemodynamic and electrophysiologic effects of combined infusion of lidocaine and propafenone in humans.
Topics: Adult; Aged; Arrhythmias, Cardiac; Electrophysiology; Female; Hemodynamics; Humans; Injections, Intravenous; Lidocaine; Male; Middle Aged; Propafenone | 1987 |
An experimental approach to the choice of antiarrhythmic therapy.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Coronary Disease; Diltiazem; Lidocaine; Mexiletine; Nifedipine; Phenoxybenzamine; Prazosin; Propafenone; Propiophenones; Propranolol; Stellate Ganglion; Verapamil | 1986 |
The usefulness of electrophysiological-pharmacologic studies in the long-term therapy of paroxysmal tachycardias.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiomyopathies; Chromatography, High Pressure Liquid; Disopyramide; Electric Stimulation; Electrocardiography; Female; Humans; Lidocaine; Male; Mexiletine; Middle Aged; Myocardial Infarction; Propafenone; Propiophenones; Quinidine; Tachycardia, Paroxysmal; Time Factors; Tocainide; Verapamil | 1985 |
New drugs in the management of ventricular arrhythmias.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bretylium Compounds; Drug Interactions; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Propafenone; Propiophenones; Tocainide | 1984 |
[Effects of anti-arrhythmia agents on heart rate. Significance and importance].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Disopyramide; Electrocardiography; Heart Conduction System; Heart Rate; Humans; Lidocaine; Propafenone; Propiophenones; Quinidine; Verapamil | 1981 |
New directions in antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Death, Sudden; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tachycardia; Tocainide; Verapamil | 1984 |
[Drug therapy of arrhythmia in coronary cardiopathy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Cardiac Complexes, Premature; Coronary Disease; Disopyramide; Electrocardiography; Humans; Lidocaine; Mexiletine; Piperidines; Propafenone; Propiophenones; Tachycardia; Tocainide | 1983 |
Worsening of arrhythmias during pharmacological treatment.
Topics: Adolescent; Adult; Aged; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Child; Disopyramide; Female; Follow-Up Studies; Humans; Lidocaine; Male; Middle Aged; Nadolol; Piperidines; Propafenone; Propanolamines; Propiophenones; Tocainide | 1984 |
Drug therapy of cardiac arrhythmias.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Biological Availability; Encainide; Half-Life; Humans; Imidazoles; Intestinal Absorption; Kinetics; Lidocaine; Metabolic Clearance Rate; Mexiletine; Propafenone; Propiophenones; Protein Binding; Tachycardia; Tocainide | 1983 |
Epicardial, endocardial and transmural mapping in assessing electrophysiological effects of 14-C lidocaine and 14-C propafenone on activation times in experimental chronic myocardial infarction. Correlations with myocardial drugs concentrations.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Carbon Radioisotopes; Coronary Circulation; Dogs; Electrophysiology; Endocardium; Heart Ventricles; Lidocaine; Myocardial Infarction; Myocardium; Propafenone; Propiophenones; Tachycardia; Ventricular Fibrillation | 1984 |
Electrophysiologic and hemodynamic effects of propafenone, a new antiarrhythmic agent, on the anesthetized, closed-chest dog: comparative study with lidocaine.
Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Blood Pressure; Cardiac Pacing, Artificial; Dogs; Electrocardiography; Electrophysiology; Female; Heart Conduction System; Heart Rate; Hemodynamics; Lidocaine; Male; Propafenone; Propiophenones | 1984 |
Suppression of ventricular arrhythmias by propafenone, a new antiarrhythmic agent, during acute myocardial infarction in the conscious dog. A comparative study with lidocaine.
Topics: Animals; Arterial Occlusive Diseases; Coronary Disease; Depression, Chemical; Diastole; Dogs; Electrocardiography; Female; Injections, Intravenous; Lidocaine; Male; Myocardial Infarction; Propafenone; Propiophenones; Sinoatrial Node; Tachycardia | 1982 |
[Therapy of ventricular tachyarrhythmias refractory to lidocaine with propafenone (author's transl)].
Topics: Administration, Oral; Adolescent; Adult; Aged; Drug Evaluation; Drug Resistance; Female; Heart Ventricles; Humans; Injections, Intravenous; Lidocaine; Male; Middle Aged; Propafenone; Propiophenones; Tachycardia; Ventricular Fibrillation | 1981 |
The influence of some cardiodepressant drugs on the histamine-induced restoration of contractility in potassium-depolarized heart preparations.
Topics: Animals; Calcium Channel Blockers; Depression, Chemical; Guinea Pigs; Histamine; In Vitro Techniques; Lidocaine; Male; Myocardial Contraction; Potassium; Propafenone; Propiophenones; Quinidine; Thiopental | 1981 |
Amiodarone is a dose-dependent noncompetitive and competitive inhibitor of T3 binding to thyroid hormone receptor subtype beta 1, whereas disopyramide, lignocaine, propafenone, metoprolol, dl-sotalol, and verapamil have no inhibitory effect.
Topics: Amiodarone; Anti-Arrhythmia Agents; Binding, Competitive; Disopyramide; Dose-Response Relationship, Drug; Humans; Lidocaine; Metoprolol; Propafenone; Receptors, Thyroid Hormone; Sotalol; Triiodothyronine; Verapamil | 1995 |
Neurotoxic action of some antiarrhythmic agents: comparative effects of propafenone, lidocaine and amiodarone on leech Retzius nerve cell.
Topics: Action Potentials; Amiodarone; Animals; Calcium; Ganglia, Invertebrate; Leeches; Lidocaine; Neurons; Patch-Clamp Techniques; Potassium; Potassium Channels; Propafenone | 1995 |
Lidocaine shows greater selective depression of depolarized and acidotic myocardium than propafenone: possible implications for proarrhythmia.
Topics: Action Potentials; Analysis of Variance; Animals; Arrhythmias, Cardiac; Female; Guinea Pigs; Heart; Hydrogen-Ion Concentration; In Vitro Techniques; Lidocaine; Male; Membrane Potentials; Microelectrodes; Myocardial Ischemia; Potassium; Propafenone | 1993 |
[Metabolism of propafenone and lidocaine in combination in rat liver supernatant].
Topics: Animals; Drug Synergism; Lidocaine; Liver; Male; Propafenone; Rats; Rats, Wistar | 1994 |
Chemically modified cardiac Na+ channels and their sensitivity to antiarrhythmics: is there a hidden drug receptor?
Topics: Animals; Anti-Arrhythmia Agents; Biological Transport; Cells, Cultured; Iodates; Lidocaine; Myocardium; Prajmaline; Propafenone; Quinidine; Rats; Receptors, Drug; Sodium Channels; Trypsin | 1994 |
Sixty-six episodes of ventricular fibrillation within four hours: electrical stability restored by propafenone.
Topics: Amiodarone; Electric Countershock; Humans; Injections, Intravenous; Lidocaine; Male; Middle Aged; Myocardial Infarction; Propafenone; Recurrence; Time Factors; Ventricular Fibrillation | 1994 |
Effects of pilsicainide on systemic hemodynamics and cardiac function of anesthetized dogs.
Topics: Anesthesia, Intravenous; Animals; Anti-Arrhythmia Agents; Depression, Chemical; Dogs; Female; Flecainide; Heart; Hemodynamics; Lidocaine; Male; Myocardial Contraction; Propafenone | 1993 |
The pharmacokinetic and pharmacodynamic interaction between propafenone and lidocaine.
Topics: Adult; Blood Pressure; Drug Interactions; Electrocardiography; Humans; Infusions, Intravenous; Lidocaine; Male; Phenotype; Propafenone; Random Allocation; Regression Analysis | 1993 |
Antiarrhythmic agents act differently on the activation phase of the ACh-response in guinea-pig atrial myocytes.
Topics: Acetylcholine; Animals; Anti-Arrhythmia Agents; Disopyramide; Electric Conductivity; Flecainide; Guinea Pigs; Lidocaine; Male; Myocardium; Potassium; Potassium Channels; Propafenone | 1993 |
Influence of duration of rapid ventricular pacing on ventricular refractoriness in the presence of propafenone and lidocaine.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrioventricular Node; Bundle of His; Cardiac Pacing, Artificial; Electric Stimulation; Electrocardiography; Female; Guinea Pigs; Heart Conduction System; Heart Rate; Heart Ventricles; Lidocaine; Male; Neural Conduction; Propafenone; Refractory Period, Electrophysiological; Regression Analysis; Sodium Channels; Time Factors | 1997 |
Effects of pilsicainide and propafenone on vagally induced atrial fibrillation: role of suppressant effect in conductivity.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Output; Dogs; Electric Conductivity; Electric Stimulation; Electrophysiology; Female; Heart Atria; Heart Rate; Humans; Lidocaine; Male; Propafenone; Vagus Nerve | 1998 |
Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine.
Topics: Cation Transport Proteins; DNA-Binding Proteins; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Flecainide; Humans; Lidocaine; Neural Inhibition; Potassium Channels; Potassium Channels, Voltage-Gated; Propafenone; Quinidine; Trans-Activators; Transcriptional Regulator ERG | 2002 |
A novel two-pore domain K+ channel, TRESK, is localized in the spinal cord.
Topics: Amino Acid Sequence; Analgesics, Non-Narcotic; Animals; Anti-Arrhythmia Agents; Arachidonic Acid; Barium; Cell Line; Cloning, Molecular; Docosahexaenoic Acids; Electrophysiology; Ethanolamines; Fatty Acids; Fatty Acids, Nonesterified; Glyburide; Humans; Hydrogen-Ion Concentration; Lidocaine; Mice; Models, Biological; Molecular Sequence Data; Patch-Clamp Techniques; Phylogeny; Potassium Channels; Propafenone; Protein Structure, Tertiary; Quinidine; Quinine; Reverse Transcriptase Polymerase Chain Reaction; Spinal Cord; Tissue Distribution; Transfection | 2003 |
Pilsicainide in breast milk from a mother: comparison with disopyramide and propafenone.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Breast Feeding; Disopyramide; Female; Humans; Lidocaine; Milk, Human; Propafenone | 2005 |
Atrial-selective sodium channel block as a strategy for suppression of atrial fibrillation.
Topics: Acetanilides; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Dogs; Electrophysiology; Heart Atria; Humans; Lidocaine; Piperazines; Propafenone; Ranolazine; Sodium Channel Blockers; Ventricular Function | 2008 |
Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia.
Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Calsequestrin; Defibrillators, Implantable; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Countershock; Electrocardiography; Flecainide; Humans; Ion Channel Gating; Lidocaine; Male; Mice; Mice, Knockout; Mutation, Missense; Myocytes, Cardiac; Procainamide; Propafenone; Ryanodine Receptor Calcium Release Channel; Sodium Channel Blockers; Tachycardia, Ventricular; Time Factors; Young Adult | 2011 |
The novel phenylpropiophenone derivates induced relaxation of isolated rat aorta.
Topics: Animals; Aorta; In Vitro Techniques; Lidocaine; Male; Nifedipine; Phenylephrine; Propafenone; Propiophenones; Rats; Rats, Wistar; Structure-Activity Relationship; Vasodilation | 2012 |
Negative Inotropic Effects of Class I Antiarrhythmics on Guinea Pig Ventricular Myocardium: Correlation with L-Type Ca
Topics: Animals; Anti-Arrhythmia Agents; Guinea Pigs; Lidocaine; Myocardium; Papillary Muscles; Propafenone | 2023 |